Topic summary

Reading a preclinical wound-healing model and its relevance to a human tendon — a second dataset

Compounds › Repair & healing peptides observational data preprint BPC-157

This is a generated summary. It shows the 9 most-liked posts from a topic of 70, in their original order, with the accepted answer included where one exists. It is a reading aid and it will miss nuance — the full topic is the record.

r.danquahTL26 Mar 2026#1

Reading a preclinical wound-healing model and its relevance to a human tendon — a second dataset — setting out what I have, and where I think it stops being reliable.

Posting a small dataset on Reading a preclinical wound-healing model. It is mine, it is uncontrolled, and the method is stated so it can be discounted appropriately.

What I would like is not agreement but a second dataset collected by someone with no stake in mine. If one exists I would rather read it than argue for this one.

50 likes 5mo

h.oyelowoTL2Regular8 Mar 2026#10

The lyophilised cake is worth looking at before adding diluent. A collapsed or shrunken cake is not a purity finding but it does say something about how the vial was made and how it travelled.

Two people can read the same figure differently here and both be reasonable.

26 likes 5mo

ni.kravchenkoTL28 Mar 2026#11

Adding a small correction to the Reading a preclinical wound-healing model summary above rather than a disagreement with it. The substance holds; one of the figures is out by a factor that matters.

29 likes 5mo

taper_fileTL3Regular11 Mar 2026 · edited#39

The most useful reply I ever got about Reading a preclinical wound-healing model was a request to state my units. It sounds like pedantry and it has saved me twice.

27 likes 5mo

e.adeyemiTL212 Mar 2026#44

sterile_table, post #2: The opening post is right about the mechanism and I think understates the practical bit. BPC-157: the preclinical literature is extensive, mostly from a small number of research groups, and reports effects across a wide range of injury models. The breadth of reported effects is itself worth noting — a compound that improves outcomes in… Go to post

Reading a preclinical wound-healing model was covered in the wiki last year and the page has a review date on it, which is a better starting point than my memory of a thread.

29 likes in reply to #2 5mo

c.dahlbergTL213 Mar 2026#52

I had written a reply contradicting post #51 and deleted it. Here is what survived.

The distinction between "no evidence it works" and "evidence it does not work": we have the first for these compounds. That is genuinely different from the second and the distinction matters, but it also means treatment plans based on these compounds are being built on theoretical grounds, not empirical ones.

31 likes 5mo

m.agyemanTL214 Mar 2026#59

Post #56 answers the question as asked. The question underneath it is different.

What would change my mind on Reading a preclinical wound-healing model is a second dataset collected by someone with no stake in the first. Until then I hold it loosely and I would rather say so than pretend to more.

30 likes 4mo

c.niemelTL3Regular14 Mar 2026#61

I think the Reading a preclinical wound-healing model question is answerable and has not been answered, which is a more optimistic position than most of this thread.

24 likes 4mo

c.adebayoTL215 Mar 2026#70

r.restrepo, post #38: Answering the question post #36 raises rather than the one it answers. BPC-157's published evidence is overwhelmingly preclinical and mostly rodent. That is not a dismissal — it is the state of the literature, and any discussion that starts elsewhere is starting from something that is not there. Go to post

Post #67 is the version of this I will quote in future. One addition.

Research use only, not approved for human use, and in this family that statement carries more weight than usual because the published human safety data is effectively absent rather than merely limited.

That has been true for the cases I have seen and I have not seen many.

23 likes in reply to #38 4mo

Read the full topic (70 posts)

Suggested topics

Topic	Participants	Replies	Views	Activity
Publication patterns in the BPC-157 literature, examined Compounds › Repair & healing peptides preprint BPC-157 TB-500 needs a source Solved Posting this under the heading it deserves: Publication patterns in the BPC-157 literature, examined Everything below is what sits behind that. Putting the numbers in the first post, because a question about…	+40	45	3.4k	21h
What would change my mind about repair peptides: a specific answer — one year on Compounds › Repair & healing peptides needs a source observational data TB-500 preprint Closed What would change my mind about repair peptides: a specific answer — one year on I have a specific reason for asking rather than idle curiosity, and the context is below. Documentation question rather than a…	+9	13	42k	19mo
Revisiting: Why the absence of controlled human data on BPC-157 matters more than people admit Compounds › Repair & healing peptides observational data TB-500 BPC-157 preprint Solved Revisiting: Why the absence of controlled human data on BPC-157 matters more than people admit Writing it up because I had to work it out twice and would rather nobody else did. A follow-up question about…	+50	55	7.8k	2d
Why plausible mechanism is not evidence of effect — one year on Compounds › Repair & healing peptides needs a source preprint BPC-157 Solved Closed The question in the title: Why plausible mechanism is not evidence of effect — one year on I will give what I have already checked below so nobody repeats it. What changes if the standard account of plausible…	+3	7	3.6k	13mo
BPC-157: what the rodent literature actually shows, and what it does not — a second dataset Compounds › Repair & healing peptides TB-500 preprint observational data needs a source Solved On the subject in the title: BPC-157: what the rodent literature actually shows, and what it does not — a second dataset Working notes rather than a conclusion. The question about BPC-157 that I actually want…	+77	84	54k	11mo

Related topics — sharing the tags observational data, preprint, BPC-157

Topic	Participants	Replies	Views	Activity
What we do not know about retatrutide, listed explicitly Compounds › Retatrutide retatrutide effect size preprint TRIUMPH programme The question in the title: What we do not know about retatrutide, listed explicitly I will give what I have already checked below so nobody repeats it. Setting out what I think I know about this compound and…	+106	113	4.8k	17mo
Revisiting: How this community labels and discusses unrefereed work Evidence › Preprints needs a source risk of bias preprint effect size Solved Revisiting: How this community labels and discusses unrefereed work Writing it up because I had to work it out twice and would rather nobody else did. Reading an unrefereed manuscript properly, and asking…	+31	35	7k	1d
Ipamorelin selectivity claims and where they came from — a second dataset Compounds › Secretagogues & GH axis CJC-1295 GHRP class tesamorelin ipamorelin Posting this under the heading it deserves: Ipamorelin selectivity claims and where they came from — a second dataset Everything below is what sits behind that. Posting a small dataset on Ipamorelin…		2	27k	14mo
Citing a preprint in a maintained document: our rule and its reasoning Evidence › Preprints risk of bias effect size needs a source preprint Pinned On the subject in the title: Citing a preprint in a maintained document: our rule and its reasoning Working notes rather than a conclusion. A preprint question rather than a question about the finding in it.…		2	467	4mo
A preprint whose numbers changed substantially at publication Evidence › Preprints preprint needs a source effect size Wiki Closed A preprint whose numbers changed substantially at publication — setting out what I have, and where I think it stops being reliable. A preprint question rather than a question about the finding in it. The…	+90	95	21k	9mo